Core Points - The Gross Law Firm has issued a notice to shareholders of Iovance Biotherapeutics, Inc. regarding a class action lawsuit for shareholders who purchased shares during the specified class period [1] - The class period is defined as May 9, 2024, to May 8, 2025, with allegations that Iovance provided misleading statements about its growth potential while concealing material adverse facts [3] - Following the announcement of disappointing financial results and a revenue guidance reduction on July 25, 2024, Iovance's stock price fell dramatically by approximately 44.795% in one day, from $3.17 to $1.75 per share [3] Allegations and Financial Impact - The complaint alleges that Iovance was not equipped to generate demand for its treatments and failed to capitalize on existing demand through its treatment centers [3] - The company attributed its poor financial results and lowered guidance to several factors, including maintenance of its iCTC, lower-than-expected Proleukin sales, and the variable pace of treatment initiation by ATCs [3] - The significant drop in stock price indicates a severe market reaction to the company's financial disclosures and guidance adjustments [3] Next Steps for Shareholders - Shareholders are encouraged to register for the class action by July 14, 2025, to participate in potential recovery efforts [4] - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [4] - There is no cost or obligation for shareholders to participate in the class action [4]

Core Viewpoint - Krispy Kreme, Inc. is facing a class action lawsuit due to allegations of misleading statements regarding the demand for its products at McDonald's locations, which has negatively impacted its financial performance and stock price [2][3]. Group 1: Allegations and Financial Impact - The class period for the lawsuit is from March 26, 2024, to May 7, 2025, during which defendants allegedly provided overly positive statements while concealing material adverse facts about product demand at McDonald's [2]. - The company reported a net revenue decline of $404 million, representing a 10.4% decrease, and a drop in average sales per store due to changing customer mix [2]. - Following the release of disappointing fourth quarter 2024 results, Krispy Kreme's stock price fell from $9.13 to $7.13, a decline of approximately 22% in one day [2]. - In the first quarter of 2025, net revenue was reported at $375.2 million, a decline of 15.3% or $67.5 million, leading to a further stock price drop from $4.33 to $3.26, a decrease of about 25% in a single day [2]. Group 2: Next Steps for Shareholders - Shareholders who purchased shares during the class period are encouraged to register for the class action by July 15, 2025, to potentially become lead plaintiffs [3]. - Registered shareholders will receive updates through a portfolio monitoring software regarding the status of the case [3]. Group 3: Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of 3D Systems Corporation regarding a class action lawsuit due to alleged misleading statements and omissions by the company during the specified class period [1][2]. Group 1: Allegations - The complaint alleges that 3D Systems Corporation understated the impact of weakened customer spending on its business while overstating its resilience in challenging industry conditions [1]. - It is also claimed that updated milestone criteria in the partnership with United Therapeutics Corporation would negatively impact the company's regenerative medicine program revenue [1]. - As a result, the company's public statements were materially false and misleading throughout the relevant times [1]. Group 2: Class Action Details - The class period for the lawsuit is from August 13, 2024, to May 12, 2025 [1]. - Shareholders are encouraged to register for the class action by the deadline of August 12, 2025, to potentially be appointed as lead plaintiff [2]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive status updates throughout the lifecycle of the case [2]. Group 3: Law Firm's Mission - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit, fraud, and illegal business practices [3]. - The firm aims to ensure that companies adhere to responsible business practices and engage in good corporate citizenship [3]. - The firm seeks recovery for investors who incurred losses due to false or misleading statements that led to artificial inflation of the company's stock [3].

Core Viewpoint - Hims & Hers Health, Inc. is facing allegations of deceptive practices related to the promotion and sale of illegitimate versions of Wegovy®, which may jeopardize its collaboration with Novo Nordisk and mislead investors about the company's prospects [2]. Group 1: Allegations and Legal Action - The class period for the allegations against Hims & Hers Health, Inc. is from April 29, 2025, to June 23, 2025 [2]. - Allegations include that Hims engaged in deceptive promotion and selling of illegitimate versions of Wegovy®, risking patient safety [2]. - The complaint suggests that the misleading statements made by the defendants about the company's business and operations lacked a reasonable basis [2]. Group 2: Shareholder Information - Shareholders who purchased shares during the class period are encouraged to register for potential lead plaintiff appointment, with a deadline of August 25, 2025 [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's status [3]. - Participation in the case incurs no cost or obligation for shareholders [3]. Group 3: Law Firm's Role - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of DoubleVerify Holdings, Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements during the class period from November 10, 2023, to February 27, 2025 [1] Allegations - Allegations include that DoubleVerify's customers shifted ad spending from open exchanges to closed platforms, limiting the company's technological capabilities [1] - The complaint states that the monetization of DoubleVerify's Activation Services was hindered due to the high costs and time required for technology development for closed platforms [1] - It is claimed that monetization of these services would take several years, impacting the company's profitability [1] - Competitors were reportedly better positioned to integrate AI into their offerings on closed platforms, further impairing DoubleVerify's competitive edge [1] - The company allegedly overbilled customers for ad impressions served to bots operating from known data centers [1] - Risk disclosures from DoubleVerify were characterized as materially false and misleading, presenting adverse facts as mere possibilities [1] - As a result of these issues, positive statements made by the defendants regarding the company's business and prospects were deemed materially false or misleading [1] Next Steps for Shareholders - Shareholders are encouraged to register for the class action by July 21, 2025, to participate in the case without any cost or obligation [2] - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [2]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Krispy Kreme, Inc. regarding a class action lawsuit due to allegations of misleading statements related to the company's partnership with McDonald's and its impact on sales performance [1][3]. Summary by Relevant Sections Allegations - The complaint alleges that Krispy Kreme's management provided overly positive statements while concealing material adverse facts about the demand for Krispy Kreme products at McDonald's locations [3]. - It is claimed that lower demand at McDonald's led to declining average weekly sales per store, and the partnership was not profitable, prompting Krispy Kreme to pause expansion into new locations [3]. Financial Performance - On February 25, 2025, Krispy Kreme reported a net revenue decline of $404 million, a decrease of 10.4%, alongside a drop in average sales per door per week due to changing customer mix [3]. - Following this announcement, the stock price fell from $9.13 per share on February 24, 2025, to $7.13 per share on February 25, 2025 [3]. - On May 8, 2025, the company reported first quarter 2025 net revenue of $375.2 million, a decline of 15.3% or $67.5 million, and announced a reassessment of its partnership with McDonald's [3]. - The stock price further declined from $4.33 per share on May 7, 2025, to $3.26 per share on May 8, 2025, representing a drop of about 25% in one day [3]. Next Steps for Shareholders - Shareholders who purchased shares during the specified class period are encouraged to register for the class action by July 15, 2025, to potentially become lead plaintiffs [4]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the lifecycle of the case [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Compass Group Diversified Holdings, LLC regarding potential legal action due to undisclosed financial issues related to its subsidiary, Lugano Holding, Inc. [1][2] Group 1: Allegations and Financial Impact - Shareholders who purchased shares of CODI from February 24, 2022, to May 7, 2025, are encouraged to contact the firm for possible lead plaintiff appointment [2] - The complaint alleges that Compass failed to disclose effective internal controls over financial reporting and critical information about Lugano, which had undisclosed financing arrangements and irregularities in sales, cost of sales, inventory, and accounts receivable [2] - Following the announcement on May 7, 2025, that its financial statements for fiscal 2024 could no longer be relied upon, Compass' stock price plummeted from $17.25 per share to $6.55 per share in one day [2] Group 2: Next Steps for Shareholders - The deadline for shareholders to register for the class action is July 8, 2025, and they will be enrolled in a portfolio monitoring software for status updates [3] - There is no cost or obligation for shareholders to participate in the case [3] Group 3: Law Firm's Mission - The Gross Law Firm aims to protect the rights of investors who have suffered due to deceit, fraud, and illegal business practices, ensuring companies adhere to responsible business practices [4]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of PepGen Inc. regarding a class action lawsuit due to allegations of misleading statements related to the company's lead product candidate, PGN-EDO51, and its clinical study [1][2]. Group 1: Allegations and Class Action Details - The class period for the allegations is from March 7, 2024, to March 3, 2025 [1]. - Allegations include that PGN-EDO51 was less effective and safe than claimed, and that the CONNECT2 study was dangerous or deficient for FDA approval [1]. - The lawsuit suggests that PepGen may halt the CONNECT2 study, and that the prospects for PGN-EDO51 were overstated [1]. Group 2: Next Steps for Shareholders - Shareholders are encouraged to register for the class action by August 8, 2025, to potentially become lead plaintiffs [2]. - Registered shareholders will receive updates through a portfolio monitoring software throughout the case [2]. Group 3: About the Gross Law Firm - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].

Core Viewpoint - Hims & Hers Health, Inc. is facing allegations of deceptive practices related to the promotion and sale of illegitimate versions of Wegovy®, which may jeopardize its collaboration with Novo Nordisk and mislead investors about the company's operations and prospects [2]. Group 1: Allegations and Class Action Details - The class period for the allegations is from April 29, 2025, to June 23, 2025 [2]. - Allegations include that Hims engaged in deceptive promotion and selling of knockoff versions of Wegovy®, risking patient safety [2]. - The complaint suggests that the misleading statements from the company could lead to the termination of its collaboration with Novo Nordisk [2]. Group 2: Shareholder Information - Shareholders are encouraged to register for the class action by August 25, 2025, to potentially become lead plaintiffs [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [3]. - Participation in the case incurs no cost or obligation for shareholders [3]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [4]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements [4].

Core Viewpoint - Hims & Hers Health, Inc. is facing a class action lawsuit due to allegations of misleading statements and deceptive practices related to the promotion of illegitimate products, which may jeopardize its collaboration with Novo Nordisk [3]. Group 1: Allegations and Class Period - The class period for the lawsuit is from April 29, 2025, to June 23, 2025 [3]. - Allegations include that Hims engaged in the deceptive promotion and selling of knockoff versions of Wegovy®, risking patient safety [3]. - The lawsuit claims that the company's positive statements about its business and prospects were materially misleading and lacked a reasonable basis due to these practices [3]. Group 2: Shareholder Information - Shareholders who purchased HIMS shares during the class period are encouraged to register for the class action, with a deadline of August 25, 2025, to seek lead plaintiff status [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [4]. - Participation in the case incurs no cost or obligation for shareholders [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and illegal business practices [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].